Register Now - Unlocking Longitudinal Patient-Reported Outcomes: The Untapped Value of Specialty Pharmacyocking
|Articles|November 19, 2009

Health Decisions Welcomes KLIXAR into the Agile Clinical Network

Health Decisions (Durham, NC) has a new company in its Agile Clinical Network, a community of research partners with the goal of higher efficiency standards in complex global studies.KLIXAR, an Argentinian CRO, has received certification after completing "rigorous" training in Agile Clinical development techniques.

“Our alliance with Health Decisions will enable us to broaden our customer base while providing unparalleled efficiency and transparency to pharmaceutical companies in Latin America,” said said Enrique Gaubeca, managing director at KLIXAR, in a company press release.

As part of the newly launched Network, KLIXAR will have access to Health Decisions’ data management systems, biostatistics expertise, medical writers, advanced data collection tools, and real-time reporting capabilities.

"We look forward to working with KLIXAR and all our Agile Clinical Network partners to raise the standards of efficiency for global clinical trials," said Rick Farris, COO at Health Decisions. "By producing rapid, accurate results for our sponsors regardless of geographic boundaries, we hope to shape the future of drug development..."

For more information about the Network, click here.


Related to this article

Where AI Leads in Trial Design—and Where Humans Still Need To
In this video interview, Claire Riches, VP of clinical solutions at Citeline, makes the case for AI as a sophisticated strategic advisor in trial design while arguing that humans must remain in the lead—especially when factors the model can't fully account for are at stake.